Adventrx becomes Mast Therapeutics to sail away from troubled chemo drug programs

The San Diego-based biotechnology firm Adventrx is capping off a turbulent past few years by changing its name to Mast Therapeutics and its stock ticker symbol from ANX to MSTX as of 11 March.